Finance

Lists
301301:SHE
Yili Chuanning Biotechnology Co Ltd
CN¥7.23
+0.56%
(+0.040) 1D
Oct 30, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301301...
Open
CN¥7.23
High
CN¥7.39
Low
CN¥7.12
Mkt. cap
16.14B
Avg. vol.
12.45M
Volume
11.63M
Dividend
2.39%
Quarterly dividend
CN¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
28.20
52-wk high
CN¥12.90
52-wk low
CN¥7.12
EPS
CN¥0.26
Shares outstanding
2.23B
No. of employees
3K
Open
CN¥7.23
High
CN¥7.39
Low
CN¥7.12
Mkt. cap
16.14B
Avg. vol.
12.45M
Volume
11.63M
Dividend
2.39%
Quarterly dividend
CN¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
28.20
52-wk high
CN¥12.90
52-wk low
CN¥7.12
EPS
CN¥0.26
Shares outstanding
2.23B
No. of employees
3K
News stories
From web sources and news partners
About Yili Chuanning Biotechnology Co Ltd
CEO-
Employees3.13K
FoundedDec 10, 2010
Headquarters-
SectorBiotechnology
Websiteklcnsw.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.18B
1.09B
1.00B
785.08M
Cost of goods sold
981.03M
836.67M
720.54M
626.68M
Cost of revenue
981.03M
836.67M
720.54M
626.68M
Research and development expenses
18.85M
22.09M
17.74M
16.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.30M
64.17M
35.39M
40.26M
Operating expense
45.95M
103.10M
73.21M
57.23M
Total operating expenses
1.03B
939.77M
793.75M
683.91M
Operating income
153.30M
154.73M
209.48M
101.16M
Other non operating income
9.26M
-8.98M
8.64M
-23.33M
EBT including unusual items
186.91M
138.71M
198.60M
67.98M
EBT excluding unusual items
159.94M
137.49M
201.32M
78.36M
Income tax expense
29.47M
28.69M
34.53M
14.96M
Effective tax rate
15.77%
20.68%
17.39%
22.01%
Other operating expenses
27.22M
17.15M
18.07M
-3.13M
Net income
157.62M
110.73M
166.78M
54.92M
Net profit margin
13.35%
10.12%
16.62%
7.00%
Earnings per share
-
-
-
-
Interest and investment income
752.74K
674.20K
856.59K
1.13M
Interest expense
-3.00M
-8.93M
-9.39M
-8.87M
Net interest expenses
-2.25M
-8.25M
-8.54M
-7.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
295.77M
297.20M
356.20M
243.63M
Gain or loss from assets sale
-345.96K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps